All Type of News
BMS returned license of anticancer Taxol
BMS Pharmaceutical Korea declared a separation from co-promotion of anticancer Taxol with Boryung Pharm, as well as Baraclude.
According to the industry concerned on the 4th, BMS Pharmaceutical Korea returned the lic...
Domestic biosimilar market will exceed USD 100 million by 2019
The domestic biosimilar market is expected to exceed USD 100 million by 2019.
The Biotech Policy Research Center expected the Korea biosimilar market will grow in the 7.8% CAGR from USD 70 million in 2012 to USD 120 ...
Foreigners own 5.13% of pharmaceutical stocks worth of KRW 4.2 trillion
Although the foreigner-owned stock portion reaches averagely 20% in the Korea stock market, it was observed the amount of foreigner-owned pharmaceutical stocks accounted barely for 5%.
That is, it means the domestic ...
100% returns for the antismoking program from the New Year, if completing the program
Today, the support business of the National Health Insurance for antismoking treatment was revised. The government is planning to increase participation of people by returning 100% of patient-sharing expenses if a pat...
Domestic avian influenza vaccine acquired approval, competing against the GSK’s product
An avian influenza vaccine developed by the domestic technology of Green Cross was approved by the Ministry of Food and Drug Safety(MFDS). It was the first time for a domestic avian vaccine to be approved; thus, depen...
Antidiabetic Suganon acquires approval as a complex
Dong-A ST, which developed Suganon(evogliptin), a domestic DPP-4 inhibitor, has quickly acquired approval of ‘Sugamet,’ a complex of evogliptin and metformin. It has only been 3 months since the approval of Suganon on...
Average price of pharmaceutical stocks increased 117% up in 2015
Stocks of listed pharmaceutical companies were observed to increase more than 100% on average in 2015 compared with the year before.
In particular, there were also stocks of 11 companies, whose prices were rapidly in...
Competition is expected to be activated between ‘Gardasil’ and ‘Cervarix’
Due to the NIP expansion, the competition between the two cervical cancer vaccines, ‘Gardasil’ and ‘Cervarix,’ will get fiercer.
The Ministry of Health and Welfare(MOHW), recently, announced that it added the ‘cervic...
‘Zydena,’ a domestic erectile dysfunction treatment’ with shocking decrease in supply price
The supply price of ‘Zydena,’ a domestic erectile dysfunction treatment developed and marketed by Dong-A ST, will be significantly decreased from the New Year.
It seems the action of the company to secure competitive...
Obligation of long-term tracking on stem cell treatments, improving safety
The government will strengthen safety management, such as obligation of long-term tracking on stem cell treatments.
On the 30th, the Ministry of Food and Drug Safety(MFDS) made the contents above through an official ...
